OpinionSeptember 14, 2021
A Renaissance for Psychedelics Could Fill a Long-Standing Treatment Gap for Psychiatric Disorders
Psilocybin and MDMA represent a first wave of therapies that help patients by changing the way they view reality
Stories by Thomas R. Insel
Thomas R. Insel is a psychiatrist and neuroscientist who served as director of the National Institute of Mental Health from 2002 to 2015. He is an adviser to Compass Pathways, as well as to several digital mental health companies, and author of Healing: Our Path from Mental Illness to Mental Health (Penguin, 2022).
Mental HealthMarch 1, 2016
Is There a Better Way to Diagnose Psychosis?
A new study opens a door to more biologically based categories of major mental illness
Mind & BrainDecember 15, 2015
Rethinking How We Diagnose Psychosis
A new study opens a door to more biologically based categories of major mental illness
Mind & BrainApril 1, 2010
Faulty Circuits
Neuroscience is revealing the malfunctioning connections underlying psychological disorders and forcing psychiatrists to rethink the causes of mental illness